CONSOLIDATED STATEMENT OF CASH FLOWS (USD $) In Thousands	12 Months Ended
	Jun. 30, 2011		Jun. 30, 2010		Jun. 30, 2009
Cash flows from operating activities:
Net (loss) income	$ (8,905)		$ 42,740		$ (124,466)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation	88,602		92,466		105,145
Amortization	9,826		9,870		9,871
Equity in (income) loss of affiliated companies	(7,228)		(11,942)		28,940
Dividends received from affiliated companies	10,023		2,404		906
Deferred income taxes	(14,711)		5,115		(3,843)
Impairment on discontinued operations			(154)		183,289
Goodwill impairment	74,100		35,277		41,661
Salon asset impairments	6,681		6,428		10,201
Note receivable bad debt expense	31,227
Excess tax benefits from stock-based compensation plans	(67)		(243)		(163)
Stock-based compensation	9,596		9,337		7,525
Amortization of debt discount and financing costs	6,469		6,406
Other noncash items affecting earnings	1,578		(3,153)		(3,405)
Changes in operating assets and liabilities:
Receivables	(2,358)	[1]	1,192	[1]	(12,104)	[1]
Inventories	4,629	[1]	4,823	[1]	7,128	[1]
Income tax receivable	23,855	[1]	957	[1]	(34,652)	[1]
Other current assets	4,725	[1]	2,657	[1]	(52)	[1]
Other assets	(11,050)	[1]	(14,951)	[1]	(1,327)	[1]
Accounts payable	(2,973)	[1]	(4,966)	[1]	(3,613)	[1]
Accrued expenses	3,341	[1]	6,006	[1]	(23,364)	[1]
Other noncurrent liabilities	1,818	[1]	1,954	[1]	387	[1]
Net cash provided by operating activities	229,178		192,223		188,064
Cash flows from investing activities:
Capital expenditures	(71,469)		(57,821)		(73,574)
Proceeds from sale of assets	626		70		77
Asset acquisitions, net of cash acquired and certain obligations assumed	(17,990)		(3,664)		(40,051)
Proceeds from loans and investments	16,804		16,099		19,008
Disbursements for loans and investments	(72,301)				(20,971)
Freestanding derivative settlement			736
Net cash used in investing activities	(144,330)		(44,580)		(115,511)
Cash flows from financing activities:
Borrowings on revolving credit facilities			337,000		6,391,100
Payments on revolving credit facilities			(342,000)		(6,525,200)
Proceeds from issuance of long-term debt, net of $5.2 million underwriting discount			167,325		85,000
Repayments of long-term debt and capital lease obligations	(137,671)		(349,175)		(92,504)
Excess tax benefits from stock-based compensation plans	67		243		163
Proceeds from issuance of common stock, net of $7.2 million underwriting discount	682		159,498		3,894
Dividends paid	(11,509)		(9,146)		(6,912)
Other			(2,878)		(3,848)
Net cash used in financing activities	(148,431)		(39,133)		(148,307)
Effect of exchange rate changes on cash and cash equivalents	7,975		823		(9,335)
(Decrease) increase in cash and cash equivalents	(55,608)		109,333		(85,089)
Cash and cash equivalents:
Beginning of year	151,871		42,538		127,627
End of year	$ 96,263		$ 151,871		$ 42,538

[1] Changes in operating assets and liabilities exclude assets acquired and liabilities assumed through acquisitions